Skip to main content

Norflex News

FDA Medwatch Alert: Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity

March 22, 2022 – Princeton, NJ, Sandoz Inc. (“Sandoz”) is initiating a voluntary recall of 13 lots (listed below) of oral Orphenadrine Citrate 100 mg Extended Release (ER) Tablets to the consumer lev...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Muscle Spasm, Migraine

Norflex patient information at Drugs.com